Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ I%p#E#[G
cC4T3]4l
'
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© pR"qPSv'
Trrh`@R
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© k mjm6
nR7\ o(!
1.Co-stimulators (or co-stimulating molecules) a5-\=0L~
MjpJAV/84
2.NK-kB Al|7Y/
yShHFlO=
3.Immunoglobulin superfamily K>[H@|k\k
q}5A^QX
4.antigen-presenting cell (APC) mw[4<vfB0a
L|X5Ru
5.death domain "b
0cj
U3}R^W~eb
6.CCR and CXCR f[b YjIX
IMza
2
7.Lectin (or mitogen) (5~C
_Y
D.(G 9H
8.Clusters of differentiation, CD) &>e
DCs
?N*0S'dY
9.B7 family +,Az\aT/%
[.X%:H+
10.Cytotoxic T lymphocyte, CTL) `l2q G#
=[JN'|Q+
11.IL-15 and IL-15 receptor (IL-15R) hZ<btN.y5
cO,V8#H
12.MHC restriction aLi_Hrb9
-kbm$~P
13.Affinity-chromatography Y/H^*1
m>ycN
14.Cyctosprin A, CsA /w M
U@MP&sdL
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) rxj@NwAno
{~fCqP.2
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© br Z,s
~AanU1U<
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 !y-2#
j yRSEk$
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ 2BDan^:-Av
=5~F6to
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ ,|X+/|gm
6@q[tN7_^
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© ]<T8ZA_Y;
;{f?? G
ÃâÒßѧרҵ£º $[iT~B$
kt{C7qpD
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ ^mueFw}\
U`8|9v
Ïû»¯ÄÚ¿Æ£º D2</^]3Su
96pk[5lj{?
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ q|o|/ O-{
=+`j?1
ѪҺ²¡Ñ§×¨Òµ£º 'B (eMnLg
hiRR+`L%
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿